share_log

津药药业(600488.SH):法莫替丁注射液通过仿制药一致性评价

Tianjin Tianyao Pharmaceuticals (600488.SH): Famotidine Injection passed the consistency evaluation of generic drugs.

Gelonghui Finance ·  Jul 24 03:45

On July 24th, Gelunhui reported that Tianjin Tianyao Pharmaceuticals (600488.SH) announced that its subsidiary, Hubei Tianyao Pharmaceuticals Co., Ltd., received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration for Famotidine Injection and approved the consistency evaluation of generic drug quality and efficacy. Famotidine injection has been marketed both domestically and internationally, mainly used for upper gastrointestinal bleeding caused by peptic ulcer disease, and gastric and duodenal mucosal erosion and bleeding caused by various reasons other than tumors and esophageal and gastric fundus varices.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment